# Clinical and Economic Outcome of Simvastatin in Critically Ill Septic Patient

> **NCT02067949** · PHASE3 · COMPLETED · sponsor: **sara mostafa amin eladawy** · enrollment: 100 (actual)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT02067949
- **Lead sponsor:** sara mostafa amin eladawy
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2015-02
- **Final completion:** 2015-03
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2015-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02067949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02067949, "Clinical and Economic Outcome of Simvastatin in Critically Ill Septic Patient". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02067949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*